CACDS introduces a web-based clinical services platform to enable community pharmacy’s ability to efficiently deliver enhanced health care services

 

The Canadian Association of Chain Drug Stores (CACDS) is leading the launch of MirixaPro Canada™, a pan-Canadian non-competitive integrated clinical decision support tool, to facilitate and accelerate the adoption of professional pharmacy services. The broadening array of pharmacy services being enabled in part by expanded professional practice scopes requires technology solutions to support service delivery to patients. To better enable the delivery of these services, CACDS selected MirixaPro™ to standardize the deployment of clinical pharmacy services across the country through the use of a common technology platform.

 

MirixaPro™, designed by pharmacists, is currently available in a broad network of pharmacies in the United States and Australia. The deployment of MirixaPro  Canada™ will enable Canadian pharmacies to more efficiently augment their dispensing services with technology to enhance pharmacy services including comprehensive medication management. MirixaPro Canada™ will enable pharmacists to electronically document patient progress, identify compliance issues, and supply educational materials. This information can then be shared with patients’ other care providers, fostering greater care and inter-professional collaboration and ultimately optimizing health outcomes.

 

• MirixaPro Canada™, our web-based clinical services platform, streamlines the data capture, data storage and reporting of medication-related patient care services.

 

• MirixaPro Canada™ will enable pharmacists to go “beyond dispensing” and position the pharmacist as a medication expert and health care professional focused on identifying, assessing and resolving medication-related problems. In addition, it supports the expanding role of a pharmacist as an educator, advisor and advocate as they actively involve patients in the proper management of their medication regimens.